Research into protein folding could pave the way to new treatments for people suffering the brain injury seen in many debilitating diseases.
It is believed that when vital proteins are misfolded in humans, debilitating diseases such as Alzheimer's or Huntington's disease occur.
However, scientists have not been able to witness the folding of some of the most crucial proteins as the process takes place inside tiny molecular chambers.
Researchers at Stanford University have now glimpsed the folding process in a study which could lead to new treatments for such conditions.
Study leader Judith Frydman said: "The mechanism of folding we saw in the chaperonin is very different from what we expected and from what has been seen in bacteria.
"It was really surprising, and we are still amazed that it worked."
This comes after scientists at the University of Edinburgh discovered an essential protein hoped to further the understanding of the brain injury seen in conditions such as multiple sclerosis, stroke and dementia.
The Nfasc186 protein sustains nerve fibres essential for the transmission of messages in the brain and could hold the key to a better understanding of neurodegenerative disease.
News from Serious Law, specialist acquired brain injury solicitors
Posted by Matthew Dixon
